Axsome Therapeutics, Inc.
REBOXETINE TO TREAT NARCOLEPSY

Last updated:

Abstract:

Described herein are methods of treating narcolepsy with cataplexy, comprising administering reboxetine to a human being in need thereof. Reboxetine may also be used in the manufacture of a medicament for the treatment of narcolepsy with cataplexy. Also disclosed herein are kits comprising a pharmaceutical composition comprising reboxetine and instructions to use the pharmaceutical composition to treat narcolepsy with cataplexy in a human being.

Status:
Application
Type:

Utility

Filling date:

23 May 2022

Issue date:

8 Sep 2022